Recent progress in understanding the epidemiology of bacterial vaginosis

Current Opinion in Obstetrics and Gynecology

Volumn 26, Issue 6, 2014, Pages 448-454

  Kenyon, Chris R ^a,b   Osbak, Kara ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bacterial vaginosis; Epidemiology; Microbiome

Indexed keywords

ADVERSE OUTCOME; AFRICAN AMERICAN; BIOFILM; CROSS-SECTIONAL STUDY; ECOLOGY; FEMALE; GARDNERELLA VAGINALIS; HISTOPATHOLOGY; HUMAN; METABOLOMICS; MICROBIAL COMMUNITY; MICROBIOME; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VAGINITIS; CLASSIFICATION; EVIDENCE BASED MEDICINE; GRAM-POSITIVE BACTERIAL INFECTIONS; GROWTH, DEVELOPMENT AND AGING; HEALTH; MALE; MICROBIOLOGY; MICROFLORA; PATHOGENICITY; PHYSIOLOGY; RISK; SEXUALITY; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; TRANSMISSION; VAGINOSIS, BACTERIAL;

BIOFILMS; EVIDENCE-BASED MEDICINE; FEMALE; GARDNERELLA VAGINALIS; GLOBAL HEALTH; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIOTA; RISK; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; VAGINOSIS, BACTERIAL;

EID: 84928080556     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000112     Document Type: Review

References (49)

1. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899-1911.
2. Marrazzo JM. Interpreting the epidemiology and natural history of bacterial vaginosis. Anaerobe 2011; 17:186-190.
3. Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013; 209:505-523. The first study to compare bacterial vaginosis prevalences using standardized criteria in different populations around the world.
4. Amsel R, Totten PA, Spiegel CA, et al. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22.
5. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
6. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States 2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34:864-869.
7. Thoma ME, Gray RH, Kiwanuka N, et al. The short-term variability of bacterial vaginosis diagnosed by Nugent Gram stain criteria among sexually active women in Rakai, Uganda. Sex Transm Dis 2011; 38:111-116.
8. Thoma ME, Gray RH, Kiwanuka N, et al. The natural history of bacterial vaginosis diagnosed by gram stain among women in Rakai. Uganda Sex Transm Dis 2011; 38:1040-1045.
9. Hickey RJ, Zhou X, Pierson JD, et al. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res 2012; 160:267-282.
10. Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007; 196:517-519.
11. Marrazzo JM, Martin DH, Watts DH, et al. Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis 2010; 37:732-744.
12. Srinivasan S, Morgan MT, Liu C, et al. More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One 2013; 8:e78633.
13. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductiveage women. Proc Natl Acad Sci U S A 2011; 108 (Suppl 1):4680-4687.
14. Borgdorff H, Tsivtsivadze E, Verhelst R, et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J 2014; 8:1781- 1793. The vaginal microbiomes of this population of African sex workers clustered into six microbiomes, three of which were obligate anaerobe dominant. In addition, L. crispatus and L. iners microbiomes were associated with lower prevalence of HIV and STIs and a lower likelihood of genital HIV detection.
15. Ravel J, Brotman RM, Gajer P, et al. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 2013; 1:29. A longitudinal study of 135 nonpregnant women who have had their vaginal microbiomes characterized daily. This study presents the initial results of 25 individuals over a 10-week period. The microbiomes of indivuals appeared to be highly personalized with some of those characterized as bacterial vaginosis (both symptomatic and asymptomatic) exhibiting rapid fluctuations and others stable community composition.
16. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 2010; 5:e10197.
17. Wen A, Srinivasan U, Goldberg D, et al. Selected vaginal bacteria and risk of preterm birth: an ecological perspective. J Infect Dis 2014; 209:1087-1094.
18. Foxman B, Wen A, Srinivasan U, et al. Mycoplasma, bacterial vaginosisassociated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort. Am J Obstet Gynecol 2014; 210:226.
19. Witkin SS, Mendes-Soares H, Linhares IM, et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio 2013; 4; pii: e00460-13.
20. Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis 2014; 209:1989-1999.
21. Petrova MI, van den Broek M, Balzarini J, et al. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev 2013; 37:762-792.
22. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010; 86:297-302.
23. Yeoman CJ, Yildirim S, Thomas SM, et al. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 2010; 5:e12411.
24. Turovskiy Y, Sutyak Noll K, Chikindas ML. The aetiology of bacterial vaginosis. J Appl Microbiol 2011; 110:1105-1128.
25. Macklaim JM, Fernandes AD, Di Bella JM, et al. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 2013; 1:12.
26. Marrazzo JM, Fiedler TL, Srinivasan S, et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis 2012; 205:1580-1588.
27. Jefferson K. Differences in the vaginal microbiome in African American and European ancestry women. 114th General Meeting of the American Society for Microbiology; Boston; 2014.
28. Bradshaw CS, Vodstrcil LA, Hocking JS, et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis 2013; 56:777-786. A detailed epidemiological study revealed that retaining the same sex partner was a risk factor for bacterial vaginosis recurrence.
29. Yeoman CJ, Thomas SM, Miller ME, et al. A multiomic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 2013; 8:e56111.
30. Swidsinski A, Loening-Baucke V, Mendling W, et al. Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol 2014; 29:567-587.
31. Swidsinski A, Doerffel Y, Loening-Baucke V, et al. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest 2010; 70:256-263.
32. Balashov SV, Mordechai E, Adelson ME, Gygax SE. Identification, quantification and subtyping of Gardnerella vaginalis in noncultured clinical vaginal samples by quantitative PCR. J Med Microbiol 2014; 63 (Pt 2):162-175.
33. Alves P, Castro J, Sousa C, et al. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. J Infect Dis 2014; 210:593.
34. Patterson JL, Stull-Lane A, Girerd PH, Jefferson KK. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology 2010; 156 (Pt 2):392-399.
35. Gilbert NM, Lewis WG, Lewis AL. Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One 2013; 8:e59539.
36. Zozaya-Hinchliffe M, Lillis R, Ferris M, et al., editors. Carriage of bacterial vaginosis-associated species by male sexual partners. American Society of Microbiology 108th General Meeting; 2008.
37. Price LB, Liu CM, Johnson KE, et al. The effects of circumcision on the penis microbiome. PLoS One 2010; 5:e8422.
38. Gray RH, Kigozi G, Serwadda D, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009; 200:42.
39. Manhart LE, Khosropour CM, Liu C, et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis 2013; 40:944-949.
40. Guedou FA, Van Damme L, Deese J, et al. Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial. BMC Infect Dis 2013; 13:208.
41. Ma L, Lv Z, Su J, et al. Consistent condom use increases the colonization of Lactobacillus crispatus in the vagina. PLoS One 2013; 8:e70716.
42. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and metaanalysis. PLoS One 2013; 8:e73055.
43. Zhou X, Brown CJ, Abdo Z, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007; 1:121-133.
44. Low AJ, Konate I, Nagot N, et al. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr 2014; 65:237-245.
45. Meda N, Sangare L, Lankoande S, et al. Pattern of sexually transmitted diseases among pregnant women in Burkina Faso, west Africa: potential for a clinical management based on simple approaches. Genitourin Med 1997; 73:188-193.
46. Gomez LM, Sammel MD, Appleby DH, et al. Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 2010; 202:386.
47. Taylor BD, Darville T, Ferrell RE, et al. Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African-American women with pelvic inflammatory disease. Sex Transm Infect 2014; pii: sextrans 051524. [Epub ahead of print]
48. Kenyon CR, Colebunders R. Strong association between the prevalence of bacterial vaginosis and male point-concurrency. Eur J Obstet Gynecol Reprod Biol 2014; 172:93-96.
49. Schwebke JR, Rivers C, Lee J. Prevalence of Gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis. Sex Transm Dis 2009; 36:92-94.